Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses

PLoS Pathogens

Volumn 5, Issue 4, 2009, Pages

  Kadaja, Meelis ^a,b   Isok Paas, Helen ^a   Laos, Triin ^a   Ustav, Ene ^a,b   Ustav, Mart ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CIRCULAR DNA; DOUBLE STRANDED DNA; GLYCOPROTEIN E1; GLYCOPROTEIN E2; HISTONE H2AX; KU ANTIGEN; MRE11 PROTEIN; NIBRIN; ONCOPROTEIN; RAD50 PROTEIN; VIRUS PROTEIN; DNA BINDING PROTEIN; E1 PROTEIN, HUMAN PAPILLOMAVIRUS 16; E2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOGENE PROTEIN E1, HUMAN PAPILLOMAVIRUS TYPE 18; ONCOGENE PROTEIN E2, HUMAN PAPILLOMAVIRUS TYPE 18;

ARTICLE; CELL ACTIVATION; CELL DIVISION; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; DNA SUPERCOILING; EPISOME; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE ACTIVATION; GENETIC CROSS; GENETIC HETEROGENEITY; GENOME; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; METAPHASE; PLASMID; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS REPLICATION; WART VIRUS; DNA REPLICATION ORIGIN; GENE TRANSLOCATION; GENETICS; HUMAN GENOME; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; PAPILLOMA VIRUS; VIRUS DNA CELL DNA INTERACTION;

ALLIUM CEPA; HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

DNA REPLICATION; DNA-BINDING PROTEINS; GENOME, HUMAN; GENOMIC INSTABILITY; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; REPLICATION ORIGIN; TRANSLOCATION, GENETIC; VIRAL PROTEINS; VIRUS INTEGRATION; VIRUS REPLICATION;

EID: 66349112294     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000397     Document Type: Article

References (80)

1. Howley PM, Lowy DR (2001) Papillomaviruses and Their Replication. Knipe DM aH, PM, eds. Philadelphia: Lippincott Williams & Wilkins. Pp 2197-2230.
2. Ustav M, Stenlund A (1991) Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. Embo J 10: 449-457.
3. Chiang CM, Ustav M, Stenlund A, Ho TF, Broker TR, et al. (1992) Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc Natl Acad Sci U S A 89: 5799-5803.
4. Sverdrup F, Khan SA (1994) Replication of human papillomavirus (HPV) DNAs supported by the HPV type 18 E1 and E2 proteins. J Virol 68: 505-509.
5. Kadaja M, Silla T, Ustav E, Ustav M (2009) Papillomavirus DNA replication - mfrom initiation to genomic instability. Virology 384: 360-368.
6. Yang L, Mohr I, Fouts E, Lim DA, Nohaile M, et al. (1993) The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase. Proc Natl Acad Sci U S A 90: 5086-5090.
7. Sedman J, Stenlund A (1998) The papillomavirus E1 protein forms a DNAdependent hexameric complex with ATPase and DNA helicase activities. J Virol 72: 6893-6897.
8. Ustav M, Ustav E, Szymanski P, Stenlund A (1991) Identification of the origin of replication of bovine papillomavirus and characterization of the viral origin recognition factor E1. Embo J 10: 4321-4329.
9. Ustav E, Ustav M, Szymanski P, Stenlund A (1993) The bovine papillomavirus origin of replication requires a binding site for the E2 transcriptional activator. Proc Natl Acad Sci U S A 90: 898-902.
10. Remm M, Brain R, Jenkins JR (1992) The E2 binding sites determine the efficiency of replication for the origin of human papillomavirus type 18. Nucleic Acids Res 20: 6015-6021.
11. Russell J, Botchan MR (1995) cis-Acting components of human papillomavirus (HPV) DNA replication: linker substitution analysis of the HPV type 11 origin. J Virol 69: 651-660.
12. Stenlund A (2003) Initiation of DNA replication: lessons from viral initiator proteins. Nat Rev Mol Cell Biol 4: 777-785.
13. Ravnan JB, Gilbert DM, Ten Hagen KG, Cohen SN (1992) Random-choice replication of extrachromosomal bovine papillomavirus (BPV) molecules in heterogeneous, clonally derived BPV-infected cell lines. J Virol 66: 6946-6952.
14. Piirsoo M, Ustav E, Mandel T, Stenlund A, Ustav M (1996) Cis and trans requirements for stable episomal maintenance of the BPV-1 replicator. Embo J 15: 1-11.
15. Cooper K, Herrington CS, Stickland JE, Evans MF, McGee JO (1991) Episomal and integrated human papillomavirus in cervical neoplasia shown by nonisotopic in situ hybridisation. J Clin Pathol 44: 990-996.
16. Kristiansen E, Jenkins A, Holm R (1994) Coexistence of episomal and integrated HPV16 DNA in squamous cell carcinoma of the cervix. J Clin Pathol 47: 253-256.
17. Alazawi W, Pett M, Arch B, Scott L, Freeman T, et al. (2002) Changes in cervical keratinocyte gene expression associated with integration of huma papillomavirus 16. Cancer Res 62: 6959-6965.
18. Peitsaro P, Hietanen S, Johansson B, Lakkala T, Syrjanen S (2002) Single copy heterozygote integration of HPV 33 in chromosomal band 5p14 is found in an epithelial cell clone with selective growth advantage. Carcinogenesis 23: 1057-1064.
19. Peitsaro P, Johansson B, Syrjanen S (2002) Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 40: 886-891.
20. Andersson S, Safari H, Mints M, Lewensohn-Fuchs I, Gyllensten U, et al. (2005) Type distribution, viral load and integration status of high-risk human papillomaviruses in pre-stages of cervical cancer (CIN). Br J Cancer 92: 2195-2200.
21. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM (2006) Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 44: 1755-1762.
22. Kulmala SM, Syrjanen SM, Gyllensten UB, Shabalova IP, Petrovichev N, et al. (2006) Early integration of high copy HPV16 detectable in women with normal and low grade cervical cytology and histology. J Clin Pathol 59: 513-517.
23. Pett MR, Herdman MT, Palmer RD, Yeo GS, Shivji MK, et al. (2006) Selection of cervical keratinocytes containing integrated HPV16 associates with episome loss and an endogenous antiviral response. Proc Natl Acad Sci U S A 103: 3822-3827.
24. Pett M, Coleman N (2007) Integration of high-risk human papillomavirus: a key event in cervical carcinogenesis? J Pathol 212: 356-367.
25. Dall KL, Scarpini CG, Roberts I, Winder DM, Stanley MA, et al. (2008) Characterization of naturally occurring HPV16 integration sites isolated from cervical keratinocytes under noncompetitive conditions. Cancer Res 68: 8249-8259.
26. Pett MR, Alazawi WO, Roberts I, Dowen S, Smith DI, et al. (2004) Acquisition of high-level chromosomal instability is associated with integration of human papillomavirus type 16 in cervical keratinocytes. Cancer Res 64: 1359-1368.
27. Jeon S, Allen-Hoffmann BL, Lambert PF (1995) Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 69: 2989-2997.
28. Romanczuk H, Howley PM (1992) Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proc Natl Acad Sci U S A 89: 3159-3163.
29. Romanczuk H, Thierry F, Howley PM (1990) Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J Virol 64: 2849-2859.
30. Kadaja M, Sumerina A, Verst T, Ojarand M, Ustav E, et al. (2007) Genomic instability of the host cell induced by the human papillomavirus replication machinery. Embo J 26: 2180-2191.
31. Corden SA, Sant-Cassia LJ, Easton AJ, Morris AG (1999) The integration of HPV-18 DNA in cervical carcinoma. Mol Pathol 52: 275-282.
32. Kalantari M, Blennow E, Hagmar B, Johansson B (2001) Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn Mol Pathol 10: 46-54.
33. Peter M, Rosty C, Couturier J, Radvanyi F, Teshima H, et al. (2006) MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene 25: 5985-5993.
34. Duensing S, Munger K (2004) Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins. Int J Cancer 109: 157-162.
35. Duensing S, Munger K (2002) The human papillomavirus type 16 E6 and E7 oncoproteins independently induce numerical and structural chromosome instability. Cancer Res 62: 7075-7082.
36. Duensing S, Munger K (2003) Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members. J Virol 77: 12331-12335.
37. Bechtold V, Beard P, Raj K (2003) Human papillomavirus type 16 E2 protein has no effect on transcription from episomal viral DNA. J Virol 77: 2021-2028.
38. Hirt B (1967) Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol 26: 365-369.
39. Cohen S, Yacobi K, Segal D (2003) Extrachromosomal circular DNA of tandemly repeated genomic sequences in Drosophila. Genome Res 13: 1133-1145.
40. Dijkwel PA, Hamlin JL (1999) Physical and genetic mapping of mammalian replication origins. Methods 18: 418-431.
41. Mannik A, Runkorg K, Jaanson N, Ustav M, Ustav E (2002) Induction of the bovine papillomavirus origin "onion skin"-type DNA replication at high E1 protein concentrations in vivo. J Virol 76: 5835-5845.
42. Meister P, Taddei A, Ponti A, Baldacci G, Gasser SM (2007) Replication foci dynamics: replication patterns are modulated by S-phase checkpoint kinases in fission yeast. Embo J 26: 1315-1326.
43. Philimonenko AA, Hodny Z, Jackson DA, Hozak P (2006) The microarchitecture of DNA replication domains. Histochem Cell Biol 125: 103-117.
44. Leonhardt H, Rahn HP, Weinzierl P, Sporbert A, Cremer T, et al. (2000) Dynamics of DNA replication factories in living cells. J Cell Biol 149: 271-280.
45. Swindle CS, Zou N, Van Tine BA, Shaw GM, Engler JA, et al. (1999) Human papillomavirus DNA replication compartments in a transient DNA replication system. J Virol 73: 1001-1009.
46. el Awady MK, Kaplan JB, O'Brien SJ, Burk RD (1987) Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa. Virology 159: 389-398.
47. Meissner JD (1999) Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J Gen Virol 80(Pt 7): 1725-1733.
48. Szuhai K, Bezrookove V, Wiegant J, Vrolijk J, Dirks RW, et al. (2000) Simultaneous molecular karyotyping and mapping of viral DNA integration sites by 25-color COBRA-FISH. Genes Chromosomes Cancer 28: 92-97.
49. Macville M, Schrock E, Padilla-Nash H, Keck C, Ghadimi BM, et al. (1999) Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res 59: 141-150.
50. Bernardi R, Pandolfi PP (2007) Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat Rev Mol Cell Biol 8: 1006-1016.
51. Shih HM, Chang CC, Kuo HY, Lin DY (2007) Daxx mediates SUMOdependent transcriptional control and subnuclear compartmentalization. Biochem Soc Trans 35: 1397-1400.
52. Weterings E, Chen DJ (2008) The endless tale of non-homologous end-joining. Cell Res 18: 114-124.
53. Shrivastav M, De Haro LP, Nickoloff JA (2008) Regulation of DNA doublestrand break repair pathway choice. Cell Res 18: 134-147.
54. Sonoda E, Hochegger H, Saberi A, Taniguchi Y, Takeda S (2006) Differential usage of non-homologous end-joining and homologous recombination in double strand break repair. DNA Repair (Amst) 5: 1021-1029.
55. Matsuoka S, Rotman G, Ogawa A, Shiloh Y, Tamai K, et al. (2000) Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc Natl Acad Sci U S A 97: 10389-10394.
56. Xu X, Tsvetkov LM, Stern DF (2002) Chk2 activation and phosphorylationdependent oligomerization. Mol Cell Biol 22: 4419-4432.
57. Buscemi G, Carlessi L, Zannini L, Lisanti S, Fontanella E, et al. (2006) DNA damage-induced cell cycle regulation and function of novel Chk2 phosphoresidues. Mol Cell Biol 26: 7832-7845.
58. Couturier J, Sastre-Garau X, Schneider-Maunoury S, Labib A, Orth G (1991) Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression. J Virol 65: 4534-4538.
59. Brink AA, Wiegant JC, Szuhai K, Tanke HJ, Kenter GG, et al. (2002) Simultaneous mapping of human papillomavirus integration sites and molecular karyotyping in short-term cultures of cervical carcinomas by using 49-color combined binary ratio labeling fluorescence in situ hybridization. Cancer Genet Cytogenet 134: 145-150.
60. Frattini MG, Lim HB, Laimins LA (1996) In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. Proc Natl Acad Sci U S A 93: 3062-3067.
61. Holmgren SC, Patterson NA, Ozbun MA, Lambert PF (2005) The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle. J Virol 79: 3938-3948.
62. Blow JJ, Dutta A (2005) Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol 6: 476-486.
63. Machida YJ, Hamlin JL, Dutta A (2005) Right place, right time, and only once: replication initiation in metazoans. Cell 123: 13-24.
64. Botchan M, Topp W, Sambrook J (1979) Studies on simian virus 40 excision from cellular chromosomes. Cold Spring Harb Symp Quant Biol 43 Pt 2: 709-719.
65. Hanahan D, Lane D, Lipsich L, Wigler M, Botchan M (1980) Characteristics of an SV40-plasmid recombinant and its movement into and out of the genome of a murine cell. Cell 21: 127-139.
66. Bullock P, Forrester W, Botchan M (1984) DNA sequence studies of simian virus 40 chromosomal excision and integration in rat cells. J Mol Biol 174: 55-84.
67. Ferguson DO, Sekiguchi JM, Chang S, Frank KM, Gao Y, et al. (2000) The nonhomologous end-joining pathway of DNA repair is required for genomic stability and the suppression of translocations. Proc Natl Acad Sci U S A 97: 6630-6633.
68. Karanjawala ZE, Grawunder U, Hsieh CL, Lieber MR (1999) The nonhomologous DNA end joining pathway is important for chromosome stability in primary fibroblasts. Curr Biol 9: 1501-1504.
69. Sharpless NE, Ferguson DO, O'Hagan RC, Castrillon DH, Lee C, et al. (2001) Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications, and deletions. Mol Cell 8: 1187-1196.
70. Zhang Y, Rowley JD (2006) Chromatin structural elements and chromosomal translocations in leukemia. DNA Repair (Amst) 5: 1282-1297.
71. Vaziri C, Saxena S, Jeon Y, Lee C, Murata K, et al. (2003) A p53-dependent checkpoint pathway prevents rereplication. Mol Cell 11: 997-1008.
72. Mihaylov IS, Kondo T, Jones L, Ryzhikov S, Tanaka J, et al. (2002) Control of DNA replication and chromosome ploidy by geminin and cyclin A. Mol Cell Biol 22: 1868-1880.
73. Zhu W, Chen Y, Dutta A (2004) Rereplication by depletion of geminin is seen regardless of p53 status and activates a G2/M checkpoint. Mol Cell Biol 24: 7140-7150.
74. Liu E, Lee AY, Chiba T, Olson E, Sun P, et al. (2007) The ATR-mediated S phase checkpoint prevents rereplication in mammalian cells when licensing control is disrupted. J Cell Biol 179: 643-657.
75. Lentz MR, Stevens SM Jr, Raynes J, Elkhoury N (2006) A phosphorylation map of the bovine papillomavirus E1 helicase. Virol J 3: 13.
76. Ilves I, Kadaja M, Ustav M (2003) Two separate replication modes of the bovine papillomavirus BPV1 origin of replication that have different sensitivity to p53. Virus Res 96: 75-84.
77. Karakaidos P, Taraviras S, Vassiliou LV, Zacharatos P, Kastrinakis NG, et al. (2004) Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability-evidence of E2F-1 transcriptional control over hCdt1. Am J Pathol 165: 1351-1365.
78. Tatsumi Y, Sugimoto N, Yugawa T, Narisawa-Saito M, Kiyono T, et al. (2006) Deregulation of Cdt1 induces chromosomal damage without rereplication and leads to chromosomal instability. J Cell Sci 119: 3128-3140.
79. Ausubel FM, RB, Kingston RE, Moore DD, Seidman JG, Struhl K (1998) Current Protocols in Molecular Biology. New York: John Wiley & Sons, Inc.
80. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd ed. New York, N.Y.: Cold Spring Harbor Laboratory Press.